PerfuseCell Cronus A/S — Credit Rating and Financial Key Figures

PerfuseCell Cronus A/S (CVR number: 31606810) is a company from HERLEV. The company recorded a gross profit of 20.5 kDKK in 2025, demonstrating a growth of 0 % compared to the previous year. The operating profit was 20.5 kDKK, while net earnings were 24 kDKK. The profitability of the company measured by Return on Assets (ROA) was 1.3 %, which can be considered weak and Return on Equity (ROE) was 2.3 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 46.9 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. PerfuseCell Cronus A/S's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.